Participatory epidemiology (PE) was used on the Borana plateau of southern Ethiopia to understand pastoralist's perceptions of the clinical and epidemiological features of foot and mouth disease (FMD) in cattle. Matrix scoring showed good agreement between informant groups on the clinical signs of acute and chronic FMD, and findings were cross-checked by clinical examination of cattle and assessment of previous clinical FMD at herd level by detection of antibody to non structural proteins of FMD virus. The positive predictive value of pastoralist's diagnosis of FMD at herd level was 93.1%. The annual age-specific incidence and mortality of acute FMD in 50 herds was estimated using proportional piling. The estimated mean incidence of acute FMD varied from in 18.5% in cattle less than two years of age to 14.0% in cattle three to four years of age. The estimated mean mortality due to acute FMD varied from 2.8% in cattle less than two years of age to 0.3% in cattle three of age or older. Pearson correlation coefficients for acute FMD by age group were -0.12 (p>0.05) for incidence and -0.59 (p<0.001) for mortality. Estimates of the annual incidence of chronic FMD varied from 0.2% in cattle less than two years of age to 1.8% in cattle three to four years of age. The Pearson correlation coefficient for the incidence of chronic FMD by age group was 0.47 (p<0.001). Outbreaks of FMD peaked in Borana cattle during the two dry seasons and were attributed to increased cattle movement to dry season grazing areas. The mean seroprevalence of FMD was estimated at 21% (n=920) and 55.2% of herds (n=116) tested seropositive. Serotyping of 120 seropositive samples indicated serotypes O (99.2%), A (95.8%), SAT 2 (80%) and C (67.5%). The endemic nature of FMD in Borana pastoral herds is discussed in terms of the direct household-level impact of the disease, and the increasing export of cattle and chilled beef from Ethiopia.
Background Cerebral palsy is one of the main causes of neurologic dysfunction in term born children. Unlike that of the developed countries, most cases of cerebral palsy are due to perinatal asphyxia which is potentially preventable. Aims This study Conducted to assess the perinatal risk factors for cerebral palsy in Tikur Anbessa Specialised hospital and to identify the possible clinical predictors of adverse neurologic outcome in asphyxiated children. Methods A case -control study which is done by review of a four year (Jul 1, 2009 to Jul 1, 2013) patient’s medical record from a registry document whose current age is greater than 8 mos. Result The result shows that 60.9%(28/46) of patients with CP had PNA in the earlier hours of neonatal life (OR: 4.95; P value 0.000) and 56% children who had had PNA have CP. The mean duration of hospital stay in patients with birth asphyxia 10 days in patients with CP as compared with control group which is 6 days and found to be a significant prognostic factor (OR= 0.411, CI: 0.11- 3.13 and P-value of 0.003. Severity of PNA at presentation is a poor prognostic factor (OR= 3.6, CI 1.7- 7.1 and P-value of 0.001). Spastic quadriplegic type of CP was found in 67.4% (31/46) children with CP. Conclusion and recommendations Based on this study there is a significant contribution of PNA for cerebral palsy in term born normal weight children. Further research is recommended to find out possible preventable risk factors for PNA.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.